Shlomit Jessel

2PUBLICATIONS
28CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jun 18, 2021
A Phase I Study of APX005M and Cabiralizumab with or without Nivolumab in Patients with Melanoma, Kidney Cancer, or Non-Small Cell Lung Cancer Resistant to Anti-PD-1/PD-L1.

Sarah A Weiss, Dijana Djureinovic, Shlomit Jessel

|Jun 11, 2021
Analysis of multispectral imaging with the AstroPath platform informs efficacy of PD-1 blockade.

Sneha Berry, Nicolas A Giraldo, Benjamin F Green

Pageof 1